CBX7
Basic information
Region (hg38): 22:39120167-39152680
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CBX7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 1 | 0 |
Variants in CBX7
This is a list of pathogenic ClinVar variants found in the CBX7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-39133944-G-A | not specified | Uncertain significance (May 09, 2023) | ||
22-39133959-T-C | not specified | Likely benign (Nov 10, 2022) | ||
22-39134006-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
22-39134031-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
22-39134036-A-G | not specified | Uncertain significance (Feb 15, 2023) | ||
22-39134038-G-T | not specified | Uncertain significance (May 05, 2023) | ||
22-39134042-G-A | not specified | Uncertain significance (May 07, 2024) | ||
22-39134404-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
22-39134416-G-C | not specified | Uncertain significance (Oct 06, 2021) | ||
22-39134437-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
22-39134454-A-G | not specified | Uncertain significance (Sep 03, 2024) | ||
22-39134455-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
22-39134524-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
22-39134644-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
22-39134745-T-C | not specified | Uncertain significance (Oct 09, 2024) | ||
22-39138655-G-C | Malignant tumor of prostate | Uncertain significance (-) | ||
22-39138674-T-C | not specified | Uncertain significance (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CBX7 | protein_coding | protein_coding | ENST00000216133 | 6 | 32508 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.685 | 0.314 | 125731 | 0 | 4 | 125735 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.30 | 108 | 153 | 0.704 | 0.0000101 | 1575 |
Missense in Polyphen | 24 | 43.668 | 0.5496 | 421 | ||
Synonymous | -0.382 | 76 | 71.9 | 1.06 | 0.00000524 | 516 |
Loss of Function | 2.75 | 2 | 12.5 | 0.161 | 6.77e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000967 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000990 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. Promotes histone H3 trimethylation at 'Lys-9' (H3K9me3). Binds to trimethylated lysine residues in histones, and possibly also other proteins. Regulator of cellular lifespan by maintaining the repression of CDKN2A, but not by inducing telomerase activity. {ECO:0000269|PubMed:19636380, ECO:0000269|PubMed:21047797, ECO:0000269|PubMed:21060834, ECO:0000269|PubMed:21282530}.;
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- 0.181
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 36.86
Haploinsufficiency Scores
- pHI
- 0.686
- hipred
- Y
- hipred_score
- 0.594
- ghis
- 0.607
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cbx7
- Phenotype
- cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; neoplasm;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;chromatin organization
- Cellular component
- nuclear chromatin;nucleus;nucleoplasm;cytosol;PcG protein complex;PRC1 complex
- Molecular function
- protein binding